Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Test Link
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Special Reports
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Google
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Special Reports
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Google
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Test Link
Brought to you by:
Biotech
Test 70 - Formatters 7/27/2026
Lorem ipsum dolor sit amet consectetur adipiscing elit. Quisque faucibus ex sapien vitae pellentesque sem placerat. In id cursus mi pretium tellus duis convallis. Tempus leo eu aenean sed diam urna tempor.
Jessica Saperstein
Jul 27, 2026 1:24pm
Royalty pens $425M deal for slice of AstraZeneca ATTR drug sales
Jul 22, 2026 10:01am
House passes bill directing FDA to update animal testing rules
Brought to you by
Google AdWords
Biotech leaders back FDA against ‘malicious’ abortion lawsuit
Jul 22, 2026 9:00am
Nobel Laureate Jennifer Doudna enters AI protein design arena
Brought to you by
AbbVie
Crystalys mines $130M series B to push gout drug through phase 3
Jul 22, 2026 8:00am
More News
Celldex ends skin disease program after failing phase 2 test
Jul 22, 2026 6:00am
Why Novartis CEO ended his ADC holdout for $1.5B Myricx deal
Jul 21, 2026 1:26pm
Jupiter enters psychedelics space with $100M deal for MDMA drug
Jul 21, 2026 10:00am
Agios says adios to sickle cell program over lackluster data
Jul 21, 2026 8:30am
See more stories